REYATAZ CAPSULE 300MG
Product details
Registration number: SIN13560P
Classification: Prescription Only
Active ingredients: ATAZANAVIR SULFATE 341.69 mg EQV ATAZANAVIR
Strength: 300 mg
Dosage form: CAPSULE
Route: ORAL
Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.
ATC code: J05AE08
HSA approval date: 8 October 2008
Manufacturer(s):
- AstraZeneca Pharmaceuticals LP
- AndersonBrecon Incorporated (Primary and Secondary Packager)
- Patheon Inc.
Manufacturing country/countries: UNITED STATES; CANADA
What are the HSA registration number and classification for REYATAZ CAPSULE 300MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN13560P
Classification: Prescription Only
What active ingredients and strength are recorded for REYATAZ CAPSULE 300MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: ATAZANAVIR SULFATE 341.69 mg EQV ATAZANAVIR
Strength: 300 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for REYATAZ CAPSULE 300MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE
Route: ORAL
Who is the recorded registrant for REYATAZ CAPSULE 300MG?
According to the HSA dataset updated 7 August 2026:
Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.
Which manufacturers and countries are listed for REYATAZ CAPSULE 300MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- AstraZeneca Pharmaceuticals LP
- AndersonBrecon Incorporated (Primary and Secondary Packager)
- Patheon Inc.
Manufacturing country/countries: UNITED STATES; CANADA
Where can I look up REYATAZ CAPSULE 300MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN13560P or the exact product name REYATAZ CAPSULE 300MG. The general register link does not preselect this product.
What are the source dates for this REYATAZ CAPSULE 300MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this REYATAZ CAPSULE 300MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN13560P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)